Tumor necrosis factor-␣ (TNF-␣)-converting enzyme (TACE, ADAM-17) is a zinc-dependent ADAM (a disintegrin and metalloproteinase) metalloproteinase (MP) of the metzincin superfamily. The enzyme regulates the shedding of a variety of cell surface-anchored molecules such as cytokines, growth factors, and receptors. The activities of the MPs are modulated by the endogenous inhibitors, the tissue inhibitor of metalloproteinases (TIMPs). Among the four mammalian TIMPs (TIMP-1 to -4), TACE is selectively inhibited by TIMP-3. The rationale for such selectivity is not fully understood. Here, we examine the molecular basis of TIMP-TACE selectivity using TIMP-2 as the scaffold. By systematically replacing the surface epitopes of TIMP-2 with those of TIMP-3 and a TIMP-1 variant V4S/TIMP-3 AB-loop/V69L/T98L, we created a novel TIMP-2 mutant that exhibits inhibitory potency almost equal to that of the TIMP-3. The affinity of the mutant with TACE is 1.49 nM, a marked improvement in comparison to that of the wild-type protein (K i 893 nM). The inhibitory pattern of the mutant is typical of that of a slow, tight binding inhibitor. We identify phenylalanine 34, a residue unique to the TIMP-3 AB-loop, as a vital element in TACE association. Mutagenesis carried out on leucine 100 also upholds our previous findings that a leucine on the EF-loop is critical for TACE recognition. Replacement of the residue by other amino acids resulted in a dramatic decrease in binding affinity, although isoleucine (L100I) and methionine (L100M) are still capable of producing the slow, tight binding effect. Our findings here represent a significant advance toward designing tailor-made TIMPs for specific MP targeting.The matrix metalloproteinases (MMPs), 1 the ADAM (a disintegrin and metalloproteinase) and the ADAM-TS (ADAM with thrombospondin repeats) proteinases are members of the mammalian metalloproteinases (MPs) of the metzincin superfamily. The enzymes are multidomain, zinc-dependent endopeptidases with a common structural feature, they all share the same tertiary configuration, termed "metzincin" fold, at the catalytic domain. Despite the similarity in structure, the functions of MPs are enormously diverse. To name a few, matrix degradation, transmembrane protein shedding, and regulation of growth factors are just some of the many physiologic processes that are known to involve the MPs (reviewed in Refs. 1-3).The enzymatic activities of the MPs are regulated by the endogenous inhibitors, the tissue inhibitor of metalloproteinases (TIMPs). There are four variants of mammalian TIMPs (TIMP-1 to -4), and each TIMP has its own profile of MP selectivity. For instance, whereas the majority of the soluble MMPs are well inhibited by all TIMP-1 to -4, membrane type MMPs and MMP-19 are less sensitive to TIMP-1 (4, 5). The ADAMs, on the other hand, are generally more sensitive to TIMP-3 than TIMP-1, -2, or -4 (6 -10). TIMPs are small molecules of ϳ22 kDa in molecular mass and variably glycosylated. The molecules are composed of two recognizable domains: (i)...